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Keywords: carcinoma; bone tumor; distal tibia; methylmethacrylate; argon beam coagulation; tibiotalocalcaneal arthrodesis C ancer metastases and pathologic fractures of the distal tibia pose a challenge to surgical reconstruction. 1 Limb salvage can be difficult due to severe bone loss and poor soft tissue quality combined with the need for postoperative adjuvant therapy. Below the knee amputation (BKA) is an established treatment option for metastatic disease to the distal tibia in patients with limited life expectancy and for palliative reasons. BKA is often performed in cases of primary malignant tumors of the distal tibia where limb salvage is not feasible and cure can be achieved. The goal of BKA is to obtain early weightbearing with a well-fitted prosthesis to improve quality of life, but the increased metabolic demand required to ambulate using a prosthesis can limit clinical outcomes. 2 The prognosis for patients with metastatic disease is generally poor. 3 Life expectancy can be difficult to predict, but is dependent on primary histology type, extent of metastatic disease, and underlying patient comorbidities. 4 Treatment options include conservative management with non-weight bearing casts, radiation therapy, chemotherapy,
Management of a Tibial Plafond Lung Cancer Metastasis Using an Intramedullary Hindfoot Fusion Nail radiofrequency ablation, and antiresorptive medications such as bisphosphonates. However, in the setting of large skeletal defects, these treatments may be insufficient. The goals of surgical reconstruction include immediate weightbearing, pain relief, lowering local tumor burden, and creation of a durable reconstruction that will outlive the patient.
Metastatic disease to the tibial plafond is very rare. 1, 5, 6 In patients with poor baseline metabolic function and in those unwilling to pursue amputation, surgical reconstruction can be performed using internal implants, Ilizarov circular frames, and custom endoprosthetic devices. However, no established treatment paradigm exists. [5] [6] [7] [8] [9] [10] Patients often cannot comply with the daily maintenance and care required for circular frames, and custom arthroplasty devices can have limited efficacy due to poor talar fixation, implant failure, and activity restrictions. 11 We believe that use of a load-sharing intramedullary hindfoot nail combined with bony stabilization using polymethylmethacrylate (PMMA) cement is an ideal treatment option for patients with severe pain, bone loss, and who desire limb salvage and early weight bearing to improve their remaining quality of life.
In this report, we discuss a rare intra-articular fracture of the medial tibial plafond with extensive bone loss due to a lung carcinoma metastasis. This is the first case report in the literature of a lung metastasis involving the tibial plafond with a pathologic fracture and long-term follow-up. 1, 6 The patient was successfully treated with limb salvage consisting of tumor excision, curettage, argon beam coagulation, tibiotalocalcaneal (TTC) arthrodesis using an intramedullary hindfoot fusion nail, and bone cementation with postoperative chemotherapy and radiation. At 1-year follow-up, the patient continues to be able to bear full weight on the extremity without a brace or assistive device and has no pain in the ankle with no local disease recurrence.
Case Report
Patient is a 74-year old woman with a positive half-pack per day smoking history for the past 51 years with progressively worsening pain and swelling in the left ankle with a reported 10-pound weight loss over the previous 6 months. She had chronic obstructive pulmonary disease and was on baseline daily oxygen at home. While working with physical therapy 3 months prior, the patient felt an acute pop in her left ankle and was found on radiography to have a radiolucent lesion occupying more than 50% of the medial tibial plafond with destruction of the medial cortex and pathologic fracture of the medial malleolus ( Figure 1 ). A percutaneous biopsy of the lesion performed by an outside physician showed normal bone and inflammatory tissue without neoplasm. Cultures were taken, which had no growth, but the patient was prophylactically given a 6-week course of intravenous antibiotics at the outside hospital for presumed osteomyelitis and no debridement was performed.
After completion of antibiotics, the patient continued to have worsening pain and swelling around the ankle and was referred to our clinic for further evaluation. On examination, the patient had a large palpable mass over the medial ankle, severe pain with ankle range of motion, and was unable to bear any weight on the left lower extremity. At that time, no work-up had been performed for primary visceral neoplasm despite her significant smoking history. Therefore, a bone scan and computed tomography scan of the chest, abdomen, and pelvis were immediately ordered to look for a visceral primary along with any other associated skeletal disease. Computed tomography scan showed 2 large lung masses without additional sites of metastases.
Two days after initial presentation we performed a repeat open biopsy using a 2-cm incision over the left tibial plafond lesion that showed poorly differentiated metastatic non-small cell lung carcinoma (NSCLC) on final pathology. The patient met with Medical and Radiation Oncology and was given a life expectancy of 6 to 9 months. Treatment options were discussed with the patient, including (a) BKA, (b) radiation therapy and antiresorptive medications in the form of denosumab or bisphosphonates, and (c) reconstruction with lesion removal and limb salvage. The patient's desired goal was to achieve pain reduction with limb salvage and early weightbearing. She did not wish to undergo Ilizarov frame placement or custom endoprosthetic reconstruction due to the prolonged recovery time and immobilization precautions associated with these options.
Given the patient's worsening pain and nonambulatory status, the patient decided to proceed with curettage and debulking of the tibial plafond lesion with cement grafting and placement of a long intramedullary hindfoot fusion nail to stabilize the left lower extremity. During surgery, the patient was positioned supine with a thigh tourniquet. A longitudinal 10-cm medial incision was first made incorporating the previous biopsy site incision and dissection was carried down through subcutaneous tissue and fascia to the level of the tumor (Figure 2 ). Fullthickness flaps were used to preserve as much soft tissue vascularity as possible to aid in postoperative wound healing and cement coverage. The posterior tibial tendon and neurovascular bundle were identified and retracted posteriorly and the tumor was removed en bloc. The excised tumor measured 3 × 5 × 2 cm and was sent for frozen section to reconfirm the diagnosis and presence of malignancy. Then, an extensive curettage of the tibial plafond was performed followed by irrigation with sterile water and normal saline.
Argon beam coagulation was used as a local adjuvant at the tumor bed, with the goal of extending the resection margins. 12 After resection and coagulation, more than 50% of the medial tibial plafond had been removed. Next, a longitudinal 8-cm incision was made over the distal fibula and dissection was carried down to the fibula and subtalar joint. An oblique-oriented fibular osteotomy was made 2.5 cm proximal to the ankle joint and the distal fibula was removed and used to create bone graft to place in the fusion sites later on. Distractors were used across the ankle and subtalar joints and all remaining cartilage was removed using a 0.25-inch curved osteotome and curettes. The joint surfaces were then perforated down to subchondral bone using a drill and curved osteotomes.
After fusion site preparation, the fibula autograft was placed in the ankle and subtalar joints and the joints were reduced into an anatomic position and provisionally pinned into place using a 0.062-inch K-wire and the guide wire for the intramedullary nail (Figure 3 ). The tibia, ankle, and hindfoot were sequentially reamed from a 9-mm reamer to a final size of 12.5 mm when appropriate bony chatter was obtained. An 11.5 × 300 mm straight hindfoot fusion nail was placed through a 3-cm incision in the central-third of the heel. The longest nail possible was used to protect the entire tibial diaphysis. Three proximal parallel interlocking screws were placed into the tibia and 2 distal interlocking screws were inserted into the calcaneus in different orientations (Figure 4) .
After confirmation of appropriate nail placement on radiography, PMMA bone cement mixed with 2 g of vancomycin powder was molded into place around the nail in the tibial plafond to recreate the distal tibia and stabilize the medial column. Once the cement was completely hardened, the wounds were thoroughly irrigated and closed in a layered fashion followed by placement of nonweightbearing splint. The patient was placed on lovenox 40 mg daily for 3 weeks for deep venous thrombosis prophylaxis along with postoperative chemotherapy and radiation targeted to the left ankle to eradicate any residual local disease. Final pathology confirmed metastatic NSCLC with an EGFR (epidermal growth factor receptor) mutation and the patient was treated with a tyrosine kinase inhibitor. Patients with EGFR-sensitive NSCLC have been shown to have prolonged survival when treated with targeted chemotherapy. 13 Sutures were removed 2 weeks after surgery with progression of weightbearing status in a tall controlled ankle motion (CAM) boot starting at 3 weeks postoperatively. She was able to bear full weight on the left lower extremity in a lace-up ankle brace 7 weeks after surgery with minimal pain using a cane for ambulation. The patient tolerated chemotherapy and radiation and was able to bear full weight on the left lower extremity without an assistive device and with no pain at 3 months postoperation. Radiographs 1 year after surgery demonstrated successful fusion across the ankle and subtalar joints without hardware failure or displacement of the medial bone cement ( Figure 5 ). She was able to ambulate approximately 3 to 4 blocks without a brace or assistive device and had no pain in the ankle with no local tumor recurrence.
Given the patient's life expectancy combined with systemic symptoms secondary to chemotherapy, the patient did not wish to pursue further surgical reconstruction in the form of cement removal and bulk autograft/allograft placement in the medial tibial plafond. Her lower extremity Musculoskeletal Tumor Society (MSTS) functional outcome score at 1-year follow-up was 27 (pain, function, emotional acceptance, walking ability, gait, and use of walking aids).
Discussion
Cancer metastases to the tibia are uncommon with reported rates of 2.6% to 5% in large series. 14, 15 In a multicenter study of 592 patients with metastatic diseases to bone, Kelly et al 6 reported that 4.4% (26) of lesions occurred in the tibia, with only 0.3% (2) of metastases in the tibia distal metaphysis (1 breast, 1 prostate). Both distal metaphyseal lesions were treated with an intramedullary hindfoot nail, but follow-up was limited to only 2 months (breast) and 8 months (prostate) due to mortality from progression of systemic disease. Of all the tibia metastases, 5/26 (19%) were found to stem from lung carcinoma and 10/26 (38%) presented with a pathologic fracture.
Patients with bony metastatic lesions are often in severe pain and have a short life expectancy due to advanced systemic tumor burden. Aggressive treatment is recommended to excise tumors and establish a stable weightbearing extremity in patients with expected survival greater than 3 months. 15 Surgical reconstruction can help relieve pain, improve mobilization, ease nursing care, decrease hospitalization costs, and significantly improve quality of life. 6 There are small case series reporting successful treatment of distal tibia lesions stemming from colon cancer, osteosarcoma, Ewing's sarcoma, adamantinoma, and malignant fibrous histiocytoma using custom tumor prostheses. 8, 10, 11 However, this can problematic in cases of tumor extension into the ankle joint as the tibiotalar biomechanics have to be reestablished in the setting of bone loss and soft tissue compromise.
Isolated ankle fusion with implants is an available option, but requires a longer period of immobilization to prevent nonunion and potential hardware failure. TTC plates require a larger soft tissue dissection, increased blood loss, and are unable to protect the length of the tibia, thus potentially having higher rates of periprosthetic fracture proximal to the plate. Intramedullary TTC hindfoot nails have the advantage of being loadsharing, can protect the entire length of the bone, and allow patients to bear weight early than other limb salvage options.
In the present case, the patient was initially misdiagnosed as having osteomyelitis of the ankle after a false negative biopsy performed at another institution. She was unnecessarily placed on 6 weeks of intravenous antibiotics with continued pain and progression of disease. In the setting of a negative biopsy but with positive medical risk factors for cancer, it is imperative to obtain a larger biopsy sample for pathologic analysis and initiate a work-up for a primary cancer source early on with the help of an oncology service. Delayed diagnosis often leads to advanced tumor growth and spread of metastases and ultimately death as patients with lung carcinoma metastases to the skeleton typically generally have less than a 6-month median survival. 3, 4 The unique aspects of the present case include the delayed presentation, diagnosis of lung carcinoma metastasis to the tibial plafond with pathologic fracture, multi-modality tumor excision with en bloc and argon beam coagulation, and successful TTC fusion with 1-year follow-up. Despite the patient having more than 50% of her medial tibial plafond excised due to tumor burden, she was able to obtain a successfully fused ankle joint clinically and radiographically. Glazebrook et al 16 investigated the extent of osseous bridging associated with good clinical outcomes in isolated hindfoot and ankle fusions and found that osseous bridging greater than 25% to 49% at the fusion site was associated with a clinically significant improvement in function with decreased pain.
The current case demonstrates that successful long-term limb salvage can be achieved with an intramedullary hindfoot fusion nail in complex cases of cancer metastases to the tibial plafond with severe bone loss. Future research is needed to determine the degree of clinical and functional improvement with these limb salvage cases along with additional fixation methods and bone graft adjuvants that may help promote early healing and bony union. A fibular osteotomy was performed followed by preparation of the ankle and subtalar joints. The ankle and subtalar joints were pinned into place using a 0.062-inch K-wire and guide wire for the intramedullary nail and radiography confirmed appropriate alignment on (A) anteroposterior, (B) lateral, and (C) heel views. 
Conclusion
Despite the poor life expectancy of many patients with cancer metastases to the distal tibia, limb salvage with an intramedullary hindfoot nail and bone cement is a viable option to reduce pain, restore function, and allow early weightbearing with an improved quality of their remaining life. (A) Anteroposterior and (B) lateral radiographs 1 year after surgery demonstrated successful ankle and subtalar fusion with stable nail, interlocking screw, and bone cement positioning. The patient was able to bear full weight on the left lower extremity without an assistive device or brace and with no pain starting at 3 months postoperatively.
